Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment
Targeted cancer treatments offer the prospect of precise inhibition of tumor growth without the untoward off-target toxicity of traditional chemotherapies. Still, unintended, often idiosyncratic side effects, such as drug-induced liver injury, can occur. We discuss the case of a 26-year-old female w...
Saved in:
Main Authors: | Gregory W. Charville, Sukhmani K. Padda, Richard K. Sibley, Ajithkumar Puthillath, Paul Y. Kwo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Hepatology |
Online Access: | http://dx.doi.org/10.1155/2018/3413592 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Treatment of Crizotinib-Induced Fulminant Liver Failure: A Case Report and Review of Literature
by: Kyle Kreitman, et al.
Published: (2020-01-01) -
Malignant Lymphoma Presenting as Fulminant Hepatic Failure
by: Elizabeth Nizalik, et al.
Published: (1989-01-01) -
Resolution of Fundic Gland Polyposis following Laparoscopic Magnetic Sphincter Augmentation and Subsequent Cessation of Proton Pump Inhibitors
by: Joel R. Brockmeyer, et al.
Published: (2015-01-01) -
Hepatic Encephalopathy and Cerebral Edema in Fulminant Liver Failure
by: Roger F Butterworth
Published: (1993-01-01) -
Fatal Fulminant Hepatic Failure in a Diabetic with Primary Dengue
by: Stalin Viswanathan, et al.
Published: (2010-01-01)